Search

J, Gaglia, and Kissler S. 2019. “Anti-CD3 Antibody for the Prevention of Type 1 Diabetes: A Story of Perseverance”. Biochemistry 58 (40): 4107-11.

Thelin, Martin, Stephan Kissler, Frederic Vigneault, Alexander Watters, Des White, Sandeep Koshy, Sarah Vermillion, David Mooney, Thomas Serwold, and Omar Ali. 2017. “In Vivo Enrichment of Diabetogenic T Cells”. Diabetes 66 (8): 2220-29.

Acharya, Mridu, Subhankar Mukhopadhyay, Helena Païdassi, Tahseen Jamil, Camille Chow, Stephan Kissler, Lynda Stuart, Richard Hynes, and Adam Lacy-Hulbert. 2010. “αv Integrin Expression by DCs Is Required for Th17 Cell Differentiation and Development of Experimental Autoimmune Encephalomyelitis in Mice”. J Clin Invest 120 (12): 4445-52.

Kissler, Stephan. 2009. “Studying Autoimmunity by in Vivo RNA Interference”. Methods Mol Biol 555: 109-18.

Thum, Thomas, Carina Gross, Jan Fiedler, Thomas Fischer, Stephan Kissler, Markus Bussen, Paolo Galuppo, et al. 2008. “MicroRNA-21 Contributes to Myocardial Disease by Stimulating MAP Kinase Signalling in Fibroblasts”. Nature 456 (7224): 980-4.

A, Haeger, Alexander S, . , Kissler S, and Friedl P. 2020. “Collective Cancer Invasion Forms an Integrin-Dependent Radioresistant Niche”. J Exp Med 217 (1).

Cai, EP, Ishikawa, Zhang, NC Leite, Li, Hou, Kiaf, et al. 2020. “Genome-Scale in Vivo CRISPR Screen Identifies RNLS As a Target for Beta Cell Protection in Type 1 Diabetes”. Nature Metabolism 2 (9): 934-45.

E, Dirice, Kahraman S, De Jesus D, . , Kissler S, and Kulkarni RN. 2019. “Increased β-Cell Proliferation Before Immune Cell Invasion Prevents Progression of Type 1 Diabetes”. Nat Metab 1 (5): 509-18.

Kissler, Stephan, and Luk Van Parijs. 2004. “Exploring the Genetic Basis of Disease Using RNA Interference”. Expert Rev Mol Diagn 4 (5): 645-51.

Kissler, Stephan, Linrong Lu, and Harvey Cantor. 2004. “Thymic Selection Can Compensate for Mutations Affecting T Cell Activation and Generate a Normal T Cell Repertoire in Mutant Mice”. Proc Natl Acad Sci U S A 101 (1): 210-4.